固定剂量组合疗法用于预防动脉样硬化心血管疾病
Anubha Agarwal1, Priya M Mehta2, Tyler Jacobson2
1Department of Medicine and Global Health Center, Washington University in St. Louis, St. Louis, MO, USA. anubha@wustl.edu.
Nature medicine
|March 27, 2024
概括
固定剂量组合疗法 (FDC) 或多药丸疗法显著降低心血管风险因素,减少死亡率和动脉样硬化心血管疾病 (ASCVD) 事件. 这一策略改善了遵守,并被推用于ASCVD的预防.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 动脉样性心血管疾病 (ASCVD) 仍然是全球领先的健康负担.
- 固定剂量组合疗法 (FDC) 或多药丸疗法,将多种药物结合到一个单一的药丸中.
- 建议使用FDC治疗来简化治疗方案,并提高对ASCVD风险因素管理的坚持.
研究的目的:
- 系统地评估FDC治疗在预防ASCVD事件中的有效性.
- 评估FDC治疗对关键风险因素,死亡率和坚持治疗的影响.
- 综合2016年至2022年间发表的随机试验的证据.
主要方法:
- 随机试验 (2016-2022) 的系统文献搜索,涉及用于ASCVD预防的FDC治疗.
- 纳入标准:至少有一种降血压药物和一种降脂药物的试验.
- 对包括死亡率,ASCVD事件,血压,LDL胆固醇和坚持在内的结果的聚合效应估计的元分析.
主要成果:
- FDC治疗显著降低低密度脂蛋白胆固醇和静脉血压.
- 与标准护理相比,FDC治疗观察到更高的坚持率.
- 在初级预防群体中,FDC疗法将全因死亡率降低了11%,ASCVD事件降低了29%;在一项二级预防试验中,主要心血管不良事件减少了24%.
结论:
- FDC治疗是有效的管理关键的心血管风险因素和改善坚持.
- 这些发现支持使用FDC疗法 (多种药物) 来降低全因死亡率和ASCVD事件.
- 实施多药药策略可以有助于降低ASCVD的全球负担.
相关概念视频
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


